Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02262039 · ClinicalTrials.gov registry record · NA
Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02262039: Completed NA study, sponsored by Yale University.
NCT02262039 is a NA study that has completed, run by Yale University. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02262039, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the Airseal System will reduce post-operative pain and reduce the need for narcotics in laparoscopic living kidney donor surgeries.
Primary Outcome
Total Morphine Equivalents - mean in mg
Interventions
- DEVICE Valveless recirculating insufflation (VTI)
- DEVICE Conventional pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-02 |
| Phase | NA |
What the finished NCT02262039 record still lists
NCT02262039 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Valveless recirculating insufflation (VTI) is the first listed.
NCT02262039 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02262039 about?
NCT02262039 is a clinical study titled "Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System". The purpose of this study is to determine if the Airseal System will reduce post-operative pain and reduce the need for narcotics in laparoscopic living kidney donor surgeries.
What is the current status of trial NCT02262039?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2014-08. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02262039?
The interventions under investigation include: Valveless recirculating insufflation (VTI) (DEVICE), Conventional pressure (DEVICE).
Who is sponsoring clinical trial NCT02262039?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02262039's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia